Clinical Trial Update: Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atorvastatin for prophylaxis of acute graft-versus-host disease in patients undergoing HLA-mon donor hematopoietic stem cell transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23